We are live on ! Find out more
DTIL icon

Precision BioSciences

130 hedge funds and large institutions have $357M invested in Precision BioSciences in 2021 Q2 according to their latest regulatory filings, with 21 funds opening new positions, 44 increasing their positions, 42 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

70% more call options, than puts

Call options by funds: $2.6M | Put options by funds: $1.53M

17% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 18

14% more capital invested

Capital invested by funds: $313M → $357M (+$44.3M)

2% more funds holding

Funds holding: 128130 (+2)

5% more repeat investments, than reductions

Existing positions increased: 44 | Existing positions reduced: 42

0.11% less ownership

Funds ownership: 1.77%1.67% (-0.11%)

Holders
130
Holders Change
+2
Holders Change %
+1.56%
% of All Funds
2.26%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
21
Increased
44
Reduced
42
Closed
18
Calls
$2.6M
Puts
$1.53M
Net Calls
+$1.07M
Net Calls Change
+$1.14M
Name Holding Trade Value Shares
Change
Change in
Stake
Voloridge Investment Management
26
Voloridge Investment Management
Florida
$2.07M -$729K -2,426 -31%
N
27
Nuveen
North Carolina
$2.06M -$107K -356 -6%
PAM
28
Panagora Asset Management
Massachusetts
$1.99M +$1.4M +4,658 +728%
Two Sigma Investments
29
Two Sigma Investments
New York
$1.9M +$1.52M +5,053 New
Bank of New York Mellon
30
Bank of New York Mellon
New York
$1.87M -$247K -824 -14%
NNP
31
Nachman Norwood & Parrott
South Carolina
$1.86M -$71.2K -237 -5%
LCM
32
Laurion Capital Management
New York
$1.85M -$793K -2,641 -35%
Susquehanna International Group
33
Susquehanna International Group
Pennsylvania
$1.78M +$477K +1,587 +50%
VC
34
Vivo Capital
California
$1.76M
Point72 Asset Management
35
Point72 Asset Management
Connecticut
$1.45M +$1.16M +3,847 New
Mirae Asset Global Investments
36
Mirae Asset Global Investments
South Korea
$1.39M +$158K +527 +17%
PP
37
PDT Partners
New York
$1.33M -$234K -779 -18%
Russell Investments Group
38
Russell Investments Group
United Kingdom
$1.29M +$601K +2,001 +140%
Rafferty Asset Management
39
Rafferty Asset Management
New York
$1.28M -$1.81M -6,025 -64%
Renaissance Technologies
40
Renaissance Technologies
New York
$1.27M -$253K -844 -20%
Swiss National Bank
41
Swiss National Bank
Switzerland
$1.26M +$180K +600 +22%
Citadel Advisors
42
Citadel Advisors
Florida
$1.16M -$1.37M -4,556 -60%
Deutsche Bank
43
Deutsche Bank
Germany
$1.08M +$264K +879 +44%
FCBT
44
First Citizens Bank & Trust
North Carolina
$1.06M +$851K +2,833 New
State Board of Administration of Florida Retirement System
45
State Board of Administration of Florida Retirement System
Florida
$1.04M +$681K +2,269 +442%
JF
46
Jump Financial
Illinois
$994K +$603K +2,009 +315%
HLA
47
Hamilton Lane Advisors
Pennsylvania
$990K
PPA
48
Parametric Portfolio Associates
Washington
$883K -$111K -368 -14%
Royal Bank of Canada
49
Royal Bank of Canada
Ontario, Canada
$874K -$40.8K -136 -6%
Wells Fargo
50
Wells Fargo
California
$840K +$10.8K +36 +2%

DTIL Hedge Fund Activity: Q2 2021 in Review

130 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Precision BioSciences (DTIL) for Q2 2021, worth a combined $357M — up 14% from $313M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new DTIL positions and 18 closed out — a net gain of 3 holders — while 44 added to existing stakes and 42 trimmed.

The largest buyer was Candriam SCA, opening a new position worth an estimated $6.34M. The largest seller was State Street, cutting an estimated $23.7M.

  • 130 institutional investors held Precision BioSciences (DTIL) as of Q2 2021, up from 128 in Q1 2021.
  • Funds reported $357M of Precision BioSciences stock for Q2 2021, up 14% quarter-over-quarter.
  • 21 funds opened new Precision BioSciences positions in Q2 2021 and 18 closed out, a net change of +3 holders.
  • The largest Precision BioSciences buyer in Q2 2021 was Candriam SCA, an estimated $6.34M added.
  • The largest Precision BioSciences seller in Q2 2021 was State Street, an estimated $23.7M sold.

Based on aggregated 13F filings for Q2 2021.